BMO Capital raised the firm’s price target on Exelon (EXC) to $51 from $49 and keeps an Outperform rating on the shares. The firm is positive on the company’s Q4 beat, better-than-expected 2026 guidance, incremental shift in growth mix towards transmission, and updated long-term growth outlook, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC: